Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

South Shore Hospital's security mistake results in $750K settlement

South Shore Hospital in Boston has agreed to pay $750,000 to resolve allegations because the provider failed to protect the personal and confidential health information of more than 800,000 consumers, Massachusetts Attorney General Martha Coakley announced. The investigation and settlement resulted from a data breach reported to the AGs office in July 2010 that included individuals names, Social Security numbers, financial account numbers and medical diagnoses.

JAMIA: Dictated EHR documentation low on quality totem pole

Which EHR documentation style best suits the quality of care a physician performs? Research published online May 19 in the Journal of the American Medical Informatics Association suggested dictated EHR documentation appears to fare worse than structured and free text documentation.

Milliman offers ACO cheat sheet

Actuarial firm Milliman has released an accountable care organization (ACO) cheat sheet to guide stakeholders through the ins and outs of Medicare Shared Savings Program and the Pioneer ACOs.

WEDI, MGMA differ on ICD-10 timeline

The staff at Centers for Medicare & Medicaid Services (CMS) likely dont have easy days at the office. With notices of proposed rulemaking being drafted with great speed relative to traditionally thought-of government timelines, the onslaught of opinions from the public to reconcile should come as no surprise. Last week, the Workgroup for Electronic Data Interchange (WEDI) and Medical Group Management Association (MGMA) offered slightly differing opinions on the ICD-10 implementation process.

Commonwealth Fund recommends core PCMH evaluation measures

To properly evaluate and compare results that will aid in the implementation of the patient centered medical home (PCMH) effort and other initiatives, the Commonwealth Fund recommended a standard set of core measures in a data brief released this month.

Circ: Medication adherence as a performance metric doesnt measure up

Medication adherence may not be a useful performance measure, based on results of a study that assessed the association between medication adherence and blood pressure control at the clinic level. Treatment intensification may be a suitable metric for gauging quality, but the authors cautioned that it may prove difficult for some providers to capture the data accurately and may have unintended adverse consequences in some hypertensive patients.

Study: Proactive approach to hospital infections could cut costly readmissions

A new study confirms the suspicion that infections contracted in hospitals correlate strongly with readmissions, prompting the authors to recommend that patients discharged with positive clinical cultures receive additional planning resources before heading home.

JACR: Radiology falls short on national safety reporting

The inception of national incident reporting systems in other medical specialties and high-risk industries has produced demonstrable improvements in safety, and radiology could realize similar benefits if the profession implemented such a system. However, medical imaging lags behind in adoption of a national system, according the authors of an article published in the May issue of Journal of American College of Radiology.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.